Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic-induced Tardive Dyskinesia”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Not applicableEnded earlyNCT00310661
What this trial is testing

Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Neuroleptic-induced Tardive Dyskinesia
Centre for Addiction and Mental Health 60
Post-approval studies (Phase 4)Looking for participantsNCT03495024
What this trial is testing

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

Who this might be right for
SchizophreniaSchizoaffective DisorderTobacco Smoking+2 more
Corporal Michael J. Crescenz VA Medical Center 10
Large-scale testing (Phase 3)Study completedNCT01543321
What this trial is testing

Xenazine in Late Dyskinetic Syndrome With Neuroleptics

Who this might be right for
Tardive Dyskinesia
Centre Hospitalier Universitaire, Amiens 54
Not applicableUnknownNCT03062033
What this trial is testing

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 70
Testing effectiveness (Phase 2)Study completedNCT00175955
What this trial is testing

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Medication-induced
UCB Pharma 70
Post-approval studies (Phase 4)WithdrawnNCT06107829
What this trial is testing

Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
Stephen Ruedrich
Post-approval studies (Phase 4)UnknownNCT00837707
What this trial is testing

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Drug-Induced
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 25
Not applicableStudy completedNCT03287778
What this trial is testing

Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaAntipsychotic Agents
University of North Carolina, Chapel Hill 17
Testing effectiveness (Phase 2)Study completedNCT01176721
What this trial is testing

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
cerbomed GmbH 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT06997198
What this trial is testing

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
University Hospitals Cleveland Medical Center 25
Early research (Phase 1)Study completedNCT00255879
What this trial is testing

Movement Disorders Caused by Antipsychotic Drugs in Older Patients

Who this might be right for
Dyskinesia, Drug-Induced
University of California, San Diego 250
Post-approval studies (Phase 4)Study completedNCT00621998
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Neuroleptic-Induced Tardive Dyskinesia
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 60
Testing effectiveness (Phase 2)Study completedNCT00401089
What this trial is testing

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderTardive Dyskinesia+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Not applicableStudy completedNCT00065286
What this trial is testing

Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation

Who this might be right for
Akathisia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)